Logo image of ULY

URGENT.LY INC (ULY) Stock Fundamental Analysis

NASDAQ:ULY - Nasdaq - US9169311084 - Common Stock - Currency: USD

0.5296  +0.04 (+8.08%)

After market: 0.5101 -0.02 (-3.68%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ULY. ULY was compared to 284 industry peers in the Software industry. ULY has a bad profitability rating. Also its financial health evaluation is rather negative. ULY has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ULY had positive earnings in the past year.
In the past year ULY has reported a negative cash flow from operations.
In the past 5 years ULY reported 4 times negative net income.
ULY had a negative operating cash flow in each of the past 5 years.
ULY Yearly Net Income VS EBIT VS OCF VS FCFULY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

ULY has a better Return On Assets (154.46%) than 100.00% of its industry peers.
Industry RankSector Rank
ROA 154.46%
ROE N/A
ROIC N/A
ROA(3y)-12.82%
ROA(5y)-37.69%
ROE(3y)222.47%
ROE(5y)92.81%
ROIC(3y)N/A
ROIC(5y)N/A
ULY Yearly ROA, ROE, ROICULY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 200 400 600

1.3 Margins

With an excellent Profit Margin value of 59.29%, ULY belongs to the best of the industry, outperforming 97.11% of the companies in the same industry.
ULY's Gross Margin of 22.21% is on the low side compared to the rest of the industry. ULY is outperformed by 85.56% of its industry peers.
In the last couple of years the Gross Margin of ULY has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 59.29%
GM 22.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.07%
GM growth 5YN/A
ULY Yearly Profit, Operating, Gross MarginsULY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -5K -10K -15K

More info and screens

0

2. Health

2.1 Basic Checks

ULY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ULY has more shares outstanding
ULY has a worse debt/assets ratio than last year.
ULY Yearly Shares OutstandingULY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
ULY Yearly Total Debt VS Total AssetsULY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

ULY has an Altman-Z score of -5.08. This is a bad value and indicates that ULY is not financially healthy and even has some risk of bankruptcy.
ULY has a worse Altman-Z score (-5.08) than 85.20% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.08
ROIC/WACCN/A
WACC21.77%
ULY Yearly LT Debt VS Equity VS FCFULY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M

2.3 Liquidity

A Current Ratio of 0.56 indicates that ULY may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.56, ULY is doing worse than 91.70% of the companies in the same industry.
ULY has a Quick Ratio of 0.56. This is a bad value and indicates that ULY is not financially healthy enough and could expect problems in meeting its short term obligations.
ULY has a Quick ratio of 0.56. This is amonst the worse of the industry: ULY underperforms 91.34% of its industry peers.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.56
ULY Yearly Current Assets VS Current LiabilitesULY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 198.99% over the past year.
ULY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.61%.
Measured over the past years, ULY shows a very strong growth in Revenue. The Revenue has been growing by 679.41% on average per year.
EPS 1Y (TTM)198.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.07%
Revenue 1Y (TTM)-18.61%
Revenue growth 3Y679.41%
Revenue growth 5YN/A
Sales Q2Q%-21.29%

3.2 Future

Based on estimates for the next years, ULY will show a very strong growth in Earnings Per Share. The EPS will grow by 26.56% on average per year.
The Revenue is expected to decrease by -1.11% on average over the next years.
EPS Next Y39.5%
EPS Next 2Y37.39%
EPS Next 3Y26.56%
EPS Next 5YN/A
Revenue Next Year-23%
Revenue Next 2Y-10.39%
Revenue Next 3Y-1.11%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ULY Yearly Revenue VS EstimatesULY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
ULY Yearly EPS VS EstimatesULY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6 -8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ULY is valuated cheaply with a Price/Earnings ratio of 0.13.
Compared to the rest of the industry, the Price/Earnings ratio of ULY indicates a rather cheap valuation: ULY is cheaper than 99.64% of the companies listed in the same industry.
ULY is valuated cheaply when we compare the Price/Earnings ratio to 28.58, which is the current average of the S&P500 Index.
ULY is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 0.13
Fwd PE N/A
ULY Price Earnings VS Forward Price EarningsULY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ULY Per share dataULY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ULY's earnings are expected to grow with 26.56% in the coming years.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y37.39%
EPS Next 3Y26.56%

More info and screens

0

5. Dividend

5.1 Amount

ULY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

URGENT.LY INC

NASDAQ:ULY (2/5/2025, 8:00:01 PM)

After market: 0.5101 -0.02 (-3.68%)

0.5296

+0.04 (+8.08%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners22.49%
Inst Owner Change-0.49%
Ins Owners7.65%
Ins Owner Change7.6%
Market Cap7.15M
Analysts80
Price Target1.53 (188.9%)
Short Float %5.13%
Short Ratio2.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.4%
Min EPS beat(2)-15.03%
Max EPS beat(2)-3.78%
EPS beat(4)2
Avg EPS beat(4)169.09%
Min EPS beat(4)-15.03%
Max EPS beat(4)672.65%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.71%
Min Revenue beat(2)-1.41%
Max Revenue beat(2)-0.01%
Revenue beat(4)1
Avg Revenue beat(4)1.43%
Min Revenue beat(4)-1.41%
Max Revenue beat(4)8.46%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)36.96%
EPS NQ rev (3m)52.46%
EPS NY rev (1m)2.02%
EPS NY rev (3m)2.02%
Revenue NQ rev (1m)-21.05%
Revenue NQ rev (3m)-16.67%
Revenue NY rev (1m)-5.76%
Revenue NY rev (3m)-5.76%
Valuation
Industry RankSector Rank
PE 0.13
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)4.04
EY762.84%
EPS(NY)-0.55
Fwd EYN/A
FCF(TTM)-6.5
FCFYN/A
OCF(TTM)-6.07
OCFYN/A
SpS11.55
BVpS-1.74
TBVpS-2.37
PEG (NY)0
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 154.46%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 59.29%
GM 22.21%
FCFM N/A
ROA(3y)-12.82%
ROA(5y)-37.69%
ROE(3y)222.47%
ROE(5y)92.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.07%
GM growth 5YN/A
F-Score5
Asset Turnover2.61
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 138.68%
Cap/Sales 3.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.56
Quick Ratio 0.56
Altman-Z -5.08
F-Score5
WACC21.77%
ROIC/WACCN/A
Cap/Depr(3y)19.88%
Cap/Depr(5y)93.64%
Cap/Sales(3y)4.85%
Cap/Sales(5y)52.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)198.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.07%
EPS Next Y39.5%
EPS Next 2Y37.39%
EPS Next 3Y26.56%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.61%
Revenue growth 3Y679.41%
Revenue growth 5YN/A
Sales Q2Q%-21.29%
Revenue Next Year-23%
Revenue Next 2Y-10.39%
Revenue Next 3Y-1.11%
Revenue Next 5YN/A
EBIT growth 1Y-50.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year42.4%
EBIT Next 3Y32.21%
EBIT Next 5YN/A
FCF growth 1Y-15.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.57%
OCF growth 3YN/A
OCF growth 5YN/A